Clinical and pharmacokinetics equivalence of multiple doses of levodopa benserazide generic formulation vs the originator (Madopar).
Margherita TortiJhessica AlessandroniDaniele BraviMiriam CasaliPaola GrassiniChiara FossatiCristiano IalongoMarco OnofrjFabiana Giada RadicatiLaura VaccaStefano BonassiFabrizio StocchiPublished in: British journal of clinical pharmacology (2019)
These findings prove the therapeutic clinical equivalence as well the PK equivalence of the generic LDB and the originator (Madopar).
Keyphrases